<DOC>
	<DOCNO>NCT00144352</DOCNO>
	<brief_summary>Plasmodium falciparum malaria HIV among important infectious disease sub-Saharan Africa . Approximately two-thirds estimate 35 million HIV infected person live sub-Saharan Africa . Of 300-500 million annual case malaria infection occur worldwide , 90 % P. falciparum infection occur sub-Saharan Africa , result approximately 1 million death , mostly child five year age . It clear HIV malaria responsible substantial disease , suffering , enormous economic burden people least afford . Although study 1993 Tanzania show significantly high prevalence malaria infection HIV-positive compare HIV negative adult , recently study show association two infection . We conduct study measure efficacy then-first line antimalarial drug ( sulfadoxine-pyrimethamine ) among patient three study arm : HIV negative , HIV infect CD4 cell count &lt; 200 , among HIV infect patient CD4 cell count &gt; = 200 . Our hypothesis patient HIV infection low CD4 cell count respond antimalarial therapy well patient HIV infect high CD4 cell count HIV negative .</brief_summary>
	<brief_title>In-Vivo Response P. Falciparum Antimalarial Treatment HIV-Infected HIV-Uninfected Adults</brief_title>
	<detailed_description>The study conduct Siaya District Hospital , Nyanza Province , Kenya . Non-pregnant adult provide consent participate , find pure Plasmodium falciparum malaria parasitemia least 500 asexual parasite per microliter , agree undergo HIV counsel test eligible participation . Clients follow repeat physical examination blood smear day 1,2,3,4,7,14,21 28 non-scheduled day sick . Those failed therapy treat quinine clear parasitemia . Samples also take measure reinfection vs. recrudescence , pharmacokinetics , antifolate resistance marker .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<mesh_term>Antimalarials</mesh_term>
	<criteria>18 year age old , pregnant . Are able make followup visit . Are able understand give inform consent . Have history fever past 24hrs current axillary temperature Â³ 37.5C . Have unmixed infection P. falciparum least 500 asexual parasites/mm3 determine microscopic examination thick and/or thin peripheral blood smear . Do evidence severe complicate malaria ( e.g. , cerebral malaria , Hb &lt; 5 g/dL , sign symptom congestive heart failure ) would require hospitalisation treatment . Have report allergy sulfa drug . Agree HIV test receive result . Less 18 yr old . Pregnant . History allergic reaction sulfa drug . Have severe complicate malaria . No history fever . Plan leave Siaya next month . Do agree HIV testing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Malaria</keyword>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
	<keyword>drug efficacy</keyword>
	<keyword>Kenya</keyword>
	<keyword>Africa</keyword>
	<keyword>Sulfadoxine pyirmethamine</keyword>
	<keyword>fansidar</keyword>
</DOC>